SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-14-378760
Filing Date
2014-10-22
Accepted
2014-10-22 16:10:38
Documents
6
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A d807746d10qa.htm 10-Q/A 28904
2 EX-10.2 d807746dex102.htm EX-10.2 140810
3 EX-31.1 d807746dex311.htm EX-31.1 8267
4 EX-31.2 d807746dex312.htm EX-31.2 8256
5 EX-32.1 d807746dex321.htm EX-32.1 3765
6 EX-32.2 d807746dex322.htm EX-32.2 3720
  Complete submission text file 0001193125-14-378760.txt   194710
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-50679 | Film No.: 141167874
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1